Track topics on Twitter Track topics that are important to you
DesignMedix has started patient enrolment in a Phase l clinical trial to evaluate the safety of its investigational drug DM1157...Read More... The post DesignMedix starts enrolment in Phase l trial of...
(Portland State University) DesignMedix' lead product, experimental anti-malaria medicine DM1157, has begun human clinical trials. DM1157, discovered at Portland State University (PSU) and developed b...
DesignMedix’s lead product, experimental anti-malaria medicine DM1157, has begun human clinical trials. DM1157, discovered at Portland State University (PSU) and developed by PS...
SummaryDesignMedix Inc DesignMedix is a biotechnology company that develop drugs to overcome drug resistance in multiple diseases such as malaria and diarrhea. The company develops malaria cure drugs,...
SummaryDesignMedix Inc DesignMedix is a biotechnology company that develop drugs to overcome drug resistance in multiple diseases including malaria and diarrhea. The company focuses on the development...
DesignMedix, Inc. was founded in 2008 to develop drugs to overcome drug resistance. The companyâs initial focus is on oral drugs to treat malaria, which kills over 600,000 pe...
We have published hundreds of DesignMedix, Inc. news stories on BioPortfolio along with dozens of DesignMedix, Inc. Clinical Trials and PubMed Articles about DesignMedix, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DesignMedix, Inc. Companies in our database. You can also find out about relevant DesignMedix, Inc. Drugs and Medications on this site too.
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...